Patent application number | Description | Published |
20140279826 | DATA FEEDS PLATFORM - A data feeds platform, comprising a data feed using a data feed protocol. The data feed protocol comprises, a feed header defining at least one identification attribute, a data header defining a data structure comprising data nodes, each data node corresponding to a subset of the data, and a data section, the data section storing the data according to the data structure. A plurality of heterogeneous data protocols is stored. A data input is received in one of the plurality of heterogeneous data protocols. The data input is converted to the data feed protocol, creating the data feed. | 09-18-2014 |
20150134595 | DATA FEEDS PLATFORM - A data feeds platform, comprising a data feed using a data feed protocol. The data feed protocol comprises, a feed header defining at least one identification attribute, a data header defining a data structure comprising data nodes, each data node corresponding to a subset of the data, and a data section, the data section storing the data according to the data structure. A plurality of heterogeneous data protocols is stored. A data input is received in one of the plurality of heterogeneous data protocols. The data input is converted to the data feed protocol, creating the data feed. | 05-14-2015 |
Patent application number | Description | Published |
20090095453 | SEALING ARRANGEMENT FOR INTERNAL TUBESHEET FOR TUBULAR HEAT EXCHANGERS - Sealing arrangement for an internal tubesheet for tubular heat exchangers comprising, a gasket fitted between a shoulder and a tubesheet, the gasket being made of spiral wound construction but without any metallic rings and without any locating groove in the adjoining components. On the outer side of the tubesheet, a channel box is provided with its inner face resting on a shoulder provided on an outer diameter of the tubesheet while the outer face of the channel box is reduced in diameter and arranged to align with the centerline of the push bolts, the outer face of the channel box resting against and attached to an annular ring and the push bolts being provided in threaded holes that reach up to the outer face of an internal flange. The push bolts, when tightened, load the annular ring, which in turn loads the gasketed joint through the channel box and the tubesheet. | 04-16-2009 |
20090120608 | SEAL FOR TUBULAR HEAT EXCHANGER - Seal for tubular heat exchanger comprising groove with an inner edge; tongue of the diaphragm having front face extending in the radial direction and inner edge parallel to the axis of the channel; the face extending beyond the radial width of the groove in inward direction and overlapping the face of the shoulder of the channel in which the groove being provided. The tongue of the diaphragm being thus kept away from entering the groove; the diaphragm having flexibility to permit deflection of the tongue, the tongue of the diaphragm being loaded from outer side by the internal compression ring, the said internal compression ring being loaded in turn by the threaded push bolts/rods being fitted in the threaded holes on periphery of the threaded lock ring. This load is ultimately transferred to the joint between the gasket and face to achieve leak-proof joint. | 05-14-2009 |
20090133862 | THREADED CHANNEL CLOSURE FOR TUBULAR HEAT EXCHANGER - Threaded channel closure for tubular heat exchanger comprising channel header wherein the gasket is provided at the shoulder of the channel, tongue of the diaphragm is provided to apply pressure on the gasket to achieve the sealed joint, outer compression ring provided at back side of the diaphragm and being loaded by push bolts, provided at the periphery of threaded lock ring, outer compression ring being supported by channel cover, which is kept in position by threaded lock ring, characterized in that, the channel header being provided with plurality of radial holes on its periphery, approximately at the centerline of the width of the outer compression ring in its assembled condition; the outer compression ring being provided with plurality of radial through holes matching the set of holes in number as well as angular position. | 05-28-2009 |
Patent application number | Description | Published |
20150201609 | TEMPERATURE CONTROLLING METHOD FOR USE IN IN-VITRO FERTILIZATION (IVF) - Disclosed is a method for maintaining temperature of a human follicle fluid containing a human oocyte. The method may comprise a warm dry block, wherein the warm dry block may be adapted to hold a plurality of tubes. The warm dry block may further be adapted to constantly maintain the temperature of the human follicle fluid containing human oocyte in the tube. In one aspect, when the tube is displaced from the warm dry block, an outer jacket may facilitate to maintain the temperature until the tube is again placed in the warm dry block. In one aspect, the tube is wrapped around with the outer jacket, wherein the outer jacket may be composed of Aluminum (Al) or Aluminum (Al) alloy. | 07-23-2015 |
20150201965 | LEVEL DETECTION OF FOLLICLE FLUID IN A TEST TUBE - The present disclosure discloses an apparatus and a method for detecting level of the follicle fluid falling into a test tube during an aspiration process. The apparatus may be configured for detecting the level of the follicle fluid falling into the test tube. Upon detecting that the level reaches the pre-defined threshold level in the test tube, the apparatus may be further configured to notify a doctor about the level of the follicle fluid into the test tube via an audio alarm or visually through the ultrasound monitor. The notification enables the doctor to concentrate on the aspiration process and further facilitates to prevent spilling of the follicle fluid from the test tube, once the follicle fluid reaches the pre-defined threshold level of the test tube. | 07-23-2015 |
20150201966 | OOCYTE RECOVERY APPARATUS AND METHOD OF ITS USE - The present disclosure discloses an apparatus and method of using such apparatus for recovering oocyte from patient's uterus. The present disclosure provides hassle-free and user-interactive experience to the user using the apparatus during the oocyte recovery process. The apparatus comprises a profile control module, a user interface module, and proportional control module. The profile control module defines a plurality of profiles. Further, each of the plurality of profiles comprises a plurality of attributes having a plurality of values. The user interface module enables a user to select a profile from the plurality of profiles and a value corresponding to each attribute of the profile selected. Further, proportional control module generates a vacuum level, via a vacuum generating unit, based upon the profile and the value select by the user. Further, the vacuum level generated may be proportionally controlled based on pressure applied on foot pedal. | 07-23-2015 |
20150201967 | DROP DETECTION OF HUMAN FOLLICLE FLUID IN A TEST TUBE - The present disclosure discloses an apparatus and a method for detecting first and subsequent drops of follicle fluid falling into a test tube during an aspiration process. A pair of optical devices (emitter and detector) is positioned at opposite side of the test tube. The emitter emits a beam of light towards the detector. As soon as a drop of the follicle fluid falls into the test tube, a signal processing circuitry detects a change in intensity of the light received by the detector. Further, the intensity of beam is compared with a pre-defined intensity. Based on the comparison, if the difference between the pre-defined intensity and intensity is greater than a pre-defined threshold value, the signal processing circuitry generates an electrical signal indicating the detection of the first drop of the follicle fluid falling into the test tube. | 07-23-2015 |
20150203080 | METHOD AND APPARATUS FOR CONTROLLING MOBILITY OF A TROLLEY - Disclosed is a method and apparatus for controlling mobility of a trolley. The apparatus may be attached to the trolley at the bottom. The apparatus may comprise an anti-skid surface and a controlling means to control the movement of the anti-skid surface. The anti-skid surface may be enabled to move vertically downward and upward, via the controlling means, thereby arresting mobility of the trolley. The downward movement of the anti-skid surface may facilitate contact between the anti-skid surface and floor thereby arresting the mobility, whereas the upward movement of the anti-skid surface may restore the mobility by disconnecting the contact between the anti-skid surface and the floor. | 07-23-2015 |
20150206675 | MULTI-FUNCTION FOOT SWITCH - Disclosed is a foot switch to be used in medical equipment for controlling various medical operations. The foot switch may comprise a foot pedal, a pressure sensor, a tilt sensor and a control unit. The pressure sensor may be adapted to sense a pressure applied on the foot pedal. The tilt sensor may be adapted to sense tilting of the foot pedal. The control unit may be configured to receive a first control signal and a second control signal from the pressure sensor and the tilt sensor respectively. The control unit may further be configured to perform a first function and a second function based upon the receipt of the first control signal and the second control respectively. The first function and the second function may be associated with controlling parameters associated with the medical equipment, thereby facilitating to control the medical operations. | 07-23-2015 |
Patent application number | Description | Published |
20090137633 | Stable pharmaceutical composition of rabeprazole - The present invention relates to a method of preparing a stable pharmaceutical composition of rabeprazole. The preparation may be used as an injectable dosage form in the treatment of severe gastric ulcers. | 05-28-2009 |
20090177008 | NOVEL PROCESS FOR SYNTHESIS OF ITOPRIDE AND ITS NOVEL INTERMEDIATE N-(4-HYDROXYBENZYL)- 3,4-DIMETHOXYBENZAMIDE - The present invention relates to a novel and improved process for the preparation of N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide—known as Itopride, via a novel intermediate N-(4˜hydroxybenzyl)-3,4-dimethoxybenzamide. | 07-09-2009 |
20100104536 | P38 INHIBITORS - The invention relates to novel p38 MAPK inhibitor which involves | 04-29-2010 |
20100113802 | PROCESS FOR PREPARING AMORPHOUS ATORVASTATIN HEMI CALCIUM SALT AND ITS ITERMEDIATE - The invention relates to the HMG-CoA reductase inhibitor in particular to Atorvastatin Hemi-calcium. The present invention is directed to novel processes for preparing amorphous form of Atorvastatin hemi calcium and their intermediate in high purity. | 05-06-2010 |
20110020440 | STABLE SOLUTIONS OF SPARINGLY SOLUBLE ACTIVES - The present invention relates to a stable pharmaceutical composition comprising soft gelatin capsules containing at least one sparingly soluble active drug (singly or in combination with sparingly soluble and/or soluble drugs) and a solvent system, wherein the solvent system comprises of solvent, co-solvent, solubilizer(s), surfactant, aqueous solution of alkali and crystal growth inhibitor. The present invention further relates to process for preparing a stable pharmaceutical composition of sparingly soluble active drug(s) in soft gelatin capsules. | 01-27-2011 |
20120014985 | Vaccine Adjuvants - The invention relates to a novel adjuvant | 01-19-2012 |
20120027849 | STABLE PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS - The present invention relates to a stable solid oral pharmaceutical multi-component composition comprising combination of blood pressure lowering drugs with lipid lowering agent/s and optionally a platelet aggregation inhibitor in a single dosage form. The blood pressure lowering agents are selected from β-adrenergic receptor blocking agent, ACE inhibitor and diuretic. The lipid lowering agent is selected from HMG Co-enzyme-A reductase inhibitor. The pharmaceutical composition made as per present invention a) overcomes any drug-drug interactions, b) exhibits pharmacokinetic and pharmacodynamic profile of individual therapeutic agent, c) has minimal side effects. The invention provides multi-component composition (MCC) to increase adherences to therapy. The MCC as per present invention provides compositions that maintain activity of all active ingredients without significant increase in adverse event profile. The present invention further relates to a method of preparing the said pharmaceutical composition. | 02-02-2012 |
20120328574 | P38 INHIBITORS - The invention relates to novel p38 MAPK inhibitor which involves | 12-27-2012 |
20130137852 | NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF - The present invention relates to process for preparation of novel compounds which are acting as inhibitors of dipeptidyl peptidase-IV enzyme and is depicted by the structural formula as given below: Formula VI. Which are useful in the treatment or prevention of diseases in which the dipeptidylpeptidase-IV enzyme is involved, such as diabetes and particularly type-2 diabetes. | 05-30-2013 |
20130225689 | PHARMACEUTICAL COMPOSITIONS OF CURCUMIN - The present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and/or molecular aggregation inhibitor(s). In accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition. | 08-29-2013 |
20130295648 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER - The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. | 11-07-2013 |
20130310447 | PHARMACEUTICAL COMPOSITION OF TAXOIDS - The present invention relates to a stable oral pharmaceutical composition with improved solubility and bioavailability; comprising a taxoid, a solubilizer, a stabilizing agent, a surfactant(s), a solvent(s), and an oil wherein the concentration of taxoid is in the range of 0.1 to 10%. | 11-21-2013 |
20130330375 | Therapeutic Cancer Vaccine - The present invention relates to vaccine(s) comprising cancer cells expressing antigen(s), excipients, optionally adjuvant wherein the said antigen(s) is expressed on contacting the said cancer cell with p38 inducer, for use in treatment of Cancer. The vaccine composition induces specific immune response against homologous and heterologus cancer cells of the tissue/organ. The invention also provides method of preparing the same. | 12-12-2013 |
20140294896 | CANCER ANTIGEN - Cancer cells when treated with cisplatin, paclitaxel, gemcitabine, | 10-02-2014 |
20150290255 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER - The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. | 10-15-2015 |
Patent application number | Description | Published |
20100209394 | MITOGEN ACTIVATED PROTEIN KINASE MODULATOR - The present invention describes the method of modulating MAPK pathways. Further more the invention describes the use of Mycobacterium w for modulation of MAPK pathway intermediates for treatment of MAPK mediated conditions. | 08-19-2010 |
20110183919 | NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS - The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme. | 07-28-2011 |
20120014985 | Vaccine Adjuvants - The invention relates to a novel adjuvant | 01-19-2012 |
20120027849 | STABLE PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS - The present invention relates to a stable solid oral pharmaceutical multi-component composition comprising combination of blood pressure lowering drugs with lipid lowering agent/s and optionally a platelet aggregation inhibitor in a single dosage form. The blood pressure lowering agents are selected from β-adrenergic receptor blocking agent, ACE inhibitor and diuretic. The lipid lowering agent is selected from HMG Co-enzyme-A reductase inhibitor. The pharmaceutical composition made as per present invention a) overcomes any drug-drug interactions, b) exhibits pharmacokinetic and pharmacodynamic profile of individual therapeutic agent, c) has minimal side effects. The invention provides multi-component composition (MCC) to increase adherences to therapy. The MCC as per present invention provides compositions that maintain activity of all active ingredients without significant increase in adverse event profile. The present invention further relates to a method of preparing the said pharmaceutical composition. | 02-02-2012 |
20120308605 | Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity - This invention discloses the process for lyophilisation of the treated cells which comprises the use of a solution containing Trehalose along with amphipathic polymer Polyvinylpyrrolidone. Further the invention discloses the process treating cancer cells, freezing, lyophilizing and reconstituting. Immunomodulator treated dead, but intact cancerous cells were recovered, which can subsequently be used for cancer immunotherapy. | 12-06-2012 |
20130150578 | NOVEL HYPOGLYCEMIC COMPOUNDS - The present invention relates to novel hypoglycemic compounds of formula (1) and pharmaceutically acceptable salts thereof. The invention relates to novel amino acid derivatives of the formula (1), wherein, A is amino acid B is peptide bond R—NH— wherein R is defined in the specification | 06-13-2013 |
20140045771 | NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS - The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme. | 02-13-2014 |
Patent application number | Description | Published |
20100148838 | WIDE RANGE DELAY CELL - A delay cell with a wider delay range is provided. The delay cell employs frequency dependent current source to generate the majority of the delay of the cell, while a control circuit (which is generally a current source that is controlled by a control voltage) provides additional delay. Thus, the delay cell provided here can be used to improve the performance of delay locked loops (DLLs) and other circuits. | 06-17-2010 |
20100164574 | SIMPLIFIED, EXTENDABLE, EDGE-BASED WATCHDOG FOR DLL - A delay locked loop (DLL) is provided. Within this DLL is a watchdog circuit that determines whether harmonic lock is present. Based on this measurement, the watchdog circuit can provide adjustments to the DLL so as to change the length of the delay of the delay line to bring it within a predetermined range. | 07-01-2010 |
20110012764 | MULTIBIT RECYCLIC PIPELINED ADC ARCHITECTURE - An apparatus is provided. The apparatus comprises a sample switch, a sampling capacitor, an amplifier, feedback branches, a second hold switch, an N-bit converter pair, a third hold switch, and an M-bit converter pair. The sample receives an input signal and is actuated by a sample signal. The sampling capacitor is coupled to the sample switch. The amplifier has a first input terminal that is coupled to the sampling capacitor. The feedback branches are coupled between the output terminal of the amplifier and the first input terminal of the amplifier, with each feedback branch including a feedback capacitor, and a first hold switch that is coupled to the feedback capacitor. The second hold switch is coupled to the sampling switch. The N-bit converter pair is coupled to the sampling switch and to the second hold switch. The third hold switch is coupled to at least one of the feedback branches, and the M-bit converter pair is coupled to the output terminal of the amplifier and to the third hold switch. | 01-20-2011 |
Patent application number | Description | Published |
20100304370 | INTRACELLULAR PH SENSOR USING NUCLEIC ACID ASSEMBLIES - Disclosed are nucleic acid-based sensors for measuring the pH of a sample, including cells, regions thereof, and whole organisms. The sensor includes an I-switch that is triggered by protons, and which functions as a FRET-based pH sensor inside living cells and organisms. Also disclosed are compositions and methods for measuring the pH of a specific region of a cell, such as vesicles, the nucleus, mitochondrial matrix, or the Golgi lumen. | 12-02-2010 |
20140335568 | NUCLEIC ACID ASSEMBLY, VECTOR, CELL, METHODS AND KIT THEREOF - The present disclosure relates to a nucleic acid assembly (NAA), comprising sensor domain and handle domain; an assembly interfaceable motif (AIM) sequence optionally along with intracellular targeting motif (ITM) sequence; and an AIM-NAA complex. It also relates to a vector comprising assembly interfaceable motif sequence optionally along with intracellular targeting motif sequence and a cell comprising the vector. Further, the instant disclosure also provides a method to obtain the nucleic acid assembly, method of intracellular targeting and kit thereof. | 11-13-2014 |